Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

Cognitive impairment in patients with Parkinson s disease is gaining increased clinical significance owing to the relative success of therapeutic approaches to the motor symptoms of this disorder Early investigations contributed to the concept of subcortical dementia associated with bradyphrenia and cognitive rigidity For cognition in parkinsonian disorders, this notion developed into the concept of mild cognitive impairment and fronto executive dysfunction in particular driven mainly by dopaminergic dysmodulation and manifesting as deficits in flexibility planning working memory and reinforcement learning However, patients with Parkinson s disease could also develop a syndrome of dementia that might depend on non dopaminergic cholinergic cortical dysfunction Recent findings supplemented by advances in neuroimaging and genetic research reveal substantial heterogeneity in the range of cognitive deficits in patients with Parkinson's disease Remediation and management prospects for these cognitive deficits are based on neuropharmacological and cognitive rehabilitation approaches.